Doreen Chan (@doreencchan) 's Twitter Profile
Doreen Chan

@doreencchan

ID: 4794774440

linkhttps://scholar.google.com/citations?user=H3zi0CUAAAAJ&hl=en calendar_today21-01-2016 20:14:12

107 Tweet

167 Takipçi

253 Takip Edilen

The Soh Lab @ Stanford (@htsohlab) 's Twitter Profile Photo

Some really cool work by Doreen Chan and Eric A. Appel on a smarter approach to developing anti-biofouling coatings for biosensors. Thanks for another great collaboration!

Doreen Chan (@doreencchan) 's Twitter Profile Photo

thanks USC Women in Molecular Biology at USC for having me as an industry panelist! a great event sharing different perspectives and experiences across academia and the biotech industry.

thanks <a href="/USC/">USC</a> <a href="/usc_wim/">Women in Molecular Biology at USC</a> for having me as an industry panelist! a great event sharing different perspectives and experiences across academia and the biotech industry.
akerotx (@akerotx) 's Twitter Profile Photo

$AKRO reports positive, statistically significant topline results for both #EFX doses on key histology endpoints in the Ph2b HARMONY study of EFX in F2/F3 #NASH #fibrosis: bit.ly/3Dleyo3 Tune in to the data presentation at 8AM ET to learn more: bit.ly/3L3U9Ww

$AKRO reports positive, statistically significant topline results for both #EFX doses on key histology endpoints in the Ph2b HARMONY study of EFX in F2/F3 #NASH #fibrosis: bit.ly/3Dleyo3 Tune in to the data presentation at 8AM ET to learn more: bit.ly/3L3U9Ww
akerotx (@akerotx) 's Twitter Profile Photo

$AKRO had a great time at #TLM22! We’re honored to have our HARMONY data presentation selected for inclusion in the “Best of the Liver Meeting” in the NALFD/#NASH category! Learn more & see top presentations: bit.ly/3UnQUgw #LiverMtg22 #LiverTwitter #EFX @AALSDtweets

$AKRO had a great time at #TLM22! We’re honored to have our HARMONY data presentation selected for inclusion in the “Best of the Liver Meeting” in the NALFD/#NASH category! Learn more &amp; see top presentations: bit.ly/3UnQUgw #LiverMtg22 #LiverTwitter #EFX @AALSDtweets
akerotx (@akerotx) 's Twitter Profile Photo

$AKRO is excited to announce that the U.S. FDA has granted Breakthrough Therapy Designation to #EFX for the treatment of #NASH. Read more: bit.ly/3ULMX4C #LiverTwitter

$AKRO is excited to announce that the <a href="/US_FDA/">U.S. FDA</a> has granted Breakthrough Therapy Designation to #EFX for the treatment of #NASH. Read more: bit.ly/3ULMX4C #LiverTwitter
Doreen Chan (@doreencchan) 's Twitter Profile Photo

happy to share my work from the Eric A. Appel on extending the longevity of implanted devices through hydrogel coatings! 🔬We synthesize and screen a subset library of hydrogels for biocompatibility in mice 🔬Demonstrate improvement over gold standard materials. 1/2

Doreen Chan (@doreencchan) 's Twitter Profile Photo

🔬Apply the selected hydrogel coating onto PDMS and insulin pumps 🔬Extend lifetime and shown improved biocompatibility of implanted pumps Thanks Caitlin Maikawa Andrea d'Aquino and collaborators at Stanford! ⭐️⭐️ Check it out here 👉doi.org/10.1002/jbm.a.… 2/2

akerotx (@akerotx) 's Twitter Profile Photo

#TeamAkero had a blast at #KSNASH23 in beautiful Alberta, Canada! Learn more about #EFX and its potential to treat #NASH by addressing all core drivers of disease progression by visiting us at akerotx.com #LiverTwitter Keystone Symposia

#TeamAkero had a blast at #KSNASH23 in beautiful Alberta, Canada! Learn more about #EFX and its potential to treat #NASH by addressing all core drivers of disease progression by visiting us at akerotx.com #LiverTwitter <a href="/KeystoneSymp/">Keystone Symposia</a>
Doreen Chan (@doreencchan) 's Twitter Profile Photo

Congrats Dr Victor Miller! Attended my first in person defense since pre COVID 😱 Thanks for sharing your work on low temperature plasma towards renewable fertilizer!

Congrats Dr Victor Miller! Attended my first in person defense since pre COVID 😱 Thanks for sharing your work on low temperature plasma towards renewable fertilizer!
Eneko Axpe (@enekoaxpe) 's Twitter Profile Photo

On my first day at the Stanford University Eric A. Appel in 2018, my labmates Doreen Chan, Hector Lopez, and Anthony Yu took me to In-N-Out. Fast forward to 2024, and we reunited yesterday! It’s wild to realize that I moved to California over 6 years ago. Time flies, but good friends last!

On my first day at the <a href="/Stanford/">Stanford University</a> <a href="/AppelGroup/">Eric A. Appel</a> in 2018, my labmates <a href="/doreencchan/">Doreen Chan</a>, <a href="/HectorLopezPhD/">Hector Lopez</a>, and <a href="/antcyu/">Anthony Yu</a> took me to In-N-Out. Fast forward to 2024, and we reunited yesterday! It’s wild to realize that I moved to California over 6 years ago. Time flies, but good friends last!
akerotx (@akerotx) 's Twitter Profile Photo

Greetings from San Diego! #TeamAkero had the pleasure of attending this year’s AASLD The Liver Meeting 2024 to connect with leading experts, share our latest data and insights, and engage in inspiring discussions about the future of MASH treatment. #TLM24 #Biotech

Greetings from San Diego! #TeamAkero had the pleasure of attending this year’s <a href="/AASLDtweets/">AASLD</a> The Liver Meeting 2024 to connect with leading experts, share our latest data and insights, and engage in inspiring discussions about the future of MASH treatment.
#TLM24 #Biotech
akerotx (@akerotx) 's Twitter Profile Photo

$AKRO announced the publication of results from the Phase 2b SYMMETRY study in NEJM. Results support the potential benefit of #EFX to elicit fibrosis improvement in patients with compensated cirrhosis (F4 fibrosis) due to #MASH. Learn more: nejm.org/doi/full/10.10…

$AKRO announced the publication of results from the Phase 2b SYMMETRY study in <a href="/NEJM/">NEJM</a>. Results support the potential benefit of #EFX to elicit fibrosis improvement in patients with compensated cirrhosis (F4 fibrosis) due to #MASH.

Learn more: nejm.org/doi/full/10.10…